Principia Biopharma Inc.
DelistedCIK 1510487fmd_1V75KHVSVKT76X0WES5ZJJ4J43Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Jun 30, 2020, 15 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Total revenues | 0 | 5 | 69 | 35 |
| Research and development | 22 | 25 | 41 | 74 |
| Total operating expenses | 27 | 32 | 52 | 94 |
| Operating income | (27) | (27) | 17 | (59) |
| Interest expense | 4 | 7 | 0 | 0 |
| Interest and investment income | 0 | 0 | 2 | 5 |
| Other non-operating income (expense) | 0 | 5 | (1) | 0 |
| Income before taxes | (31) | (29) | 18 | (54) |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (31) | (29) | 18 | (54) |
| Net income | (31) | (29) | 18 | – |
| Net income to common shareholders | (31) | (29) | 5 | (54) |